{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:50:00Z","timestamp":1782219000604,"version":"3.54.5"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012323","name":"CSIR - Indian Institute of Chemical Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejphar.2022.175187","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T21:20:02Z","timestamp":1659993602000},"page":"175187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel benzoxazinone derivative as potent human neutrophil elastase inhibitor: Potential implications in lung injury"],"prefix":"10.1016","volume":"931","author":[{"given":"Sayantan","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jala Ranjith","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomula","family":"Rajesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulaganathan","family":"Mabalirajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha Krishna","family":"Palakodety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulok","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1183\/09031936.03.00405703","article-title":"Systemic effects of chronic obstructive pulmonary disease","volume":"21","author":"Agust\u00ed","year":"2003","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175187_bib2","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1021\/acsomega.8b00702","article-title":"Diazaborines as new inhibitors of human neutrophil elastase","volume":"3","author":"Ant\u00f3nio","year":"2018","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.10332","article-title":"Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding","volume":"92","author":"Banker","year":"2003","journal-title":"J. Pharmaceut. Sci."},{"issue":"2 Suppl. l","key":"10.1016\/j.ejphar.2022.175187_bib4","article-title":"Mechanisms in COPD: differences from asthma","volume":"117","author":"Barnes","year":"2000","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib6","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/bi00431a001","article-title":"Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors","volume":"28","author":"Bode","year":"1989","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.ejphar.2022.175187_bib7","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1021\/jm500782s","article-title":"Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3","volume":"57","author":"Budnjo","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.175187_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bioorg.2019.01.040","article-title":"Synthesis and structure-activity relationship of elastase inhibiting novel ethylated thiazole-triazole acetamide hybrids: mechanistic insights through kinetics and computational contemplations","volume":"86","author":"Butt","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.184.4.1213","article-title":"Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b\/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion","volume":"184","author":"Cai","year":"1996","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00441-009-0887-6","article-title":"Proteinases involved in matrix turnover during cartilage and bone breakdown","volume":"339","author":"Cawston","year":"2010","journal-title":"Cell Tissue Res."},{"issue":"Pt 12","key":"10.1016\/j.ejphar.2022.175187_bib11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1242\/jcs.112.12.1937","article-title":"PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front","volume":"112","author":"Cepinskas","year":"1999","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1513\/pats.200603-078AW","article-title":"Neutrophil elastase: mediator of extracellular matrix destruction and accumulation","volume":"3","author":"Chua","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"21","key":"10.1016\/j.ejphar.2022.175187_bib13","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1016\/j.bmc.2018.09.034","article-title":"1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors","volume":"26","author":"Crocetti","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175187_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ddr.21323","article-title":"Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors","volume":"77","author":"Crocetti","year":"2016","journal-title":"Drug Dev. Res."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib15","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1021\/acs.jmedchem.1c01583","article-title":"Elastase inhibitor cyclotheonellazole A: total synthesis and in vivo biological evaluation for acute lung injury","volume":"65","author":"Cui","year":"2022","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejphar.2022.175187_bib16","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/00003495-200363190-00002","article-title":"Therapy for chronic obstructive pulmonary disease in the 21st century","volume":"63","author":"Donnelly","year":"2003","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-3565(25)22353-9","article-title":"Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase","volume":"270","author":"Durham","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/med.2610140202","article-title":"Synthetic inhibitors of elastase","volume":"14","author":"Edwards","year":"1994","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1378\/chest.13-0809","article-title":"COPD surveillance--United States, 1999-2011","volume":"144","author":"Ford","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOH.0000000000000009","article-title":"The role of neutrophils in cystic fibrosis","volume":"21","author":"Gifford","year":"2014","journal-title":"Curr. Opin. Hematol."},{"issue":"3\u20134","key":"10.1016\/j.ejphar.2022.175187_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2119\/molmed.2010.00138","article-title":"Contribution of neutrophils to acute lung injury","volume":"17","author":"Grommes","year":"2011","journal-title":"Mol. Med. (Camb.)"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/156802606776287054","article-title":"Targeting serine proteases in asthma","volume":"6","author":"Guay","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175187_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.06.00124605","article-title":"Global burden of COPD: systematic review and meta-analysis","volume":"28","author":"Halbert","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOH.0000000000000001","article-title":"The potential of neutrophil elastase inhibitors as anti-inflammatory therapies","volume":"21","author":"Henriksen","year":"2014","journal-title":"Curr. Opin. Hematol."},{"issue":"6\u20137","key":"10.1016\/j.ejphar.2022.175187_bib25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.biocel.2008.01.004","article-title":"Human neutrophil elastase: mediator and therapeutic target in atherosclerosis","volume":"40","author":"Henriksen","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"16","key":"10.1016\/j.ejphar.2022.175187_bib26","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1074\/jbc.M300351200","article-title":"Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration","volume":"278","author":"Hermant","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"11\u201312","key":"10.1016\/j.ejphar.2022.175187_bib27","article-title":"Serine proteases of the human immune system in health and disease","volume":"47","author":"Heutinck","year":"2010","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175187_bib28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0016-5085(89)90897-4","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"issue":"9435","key":"10.1016\/j.ejphar.2022.175187_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(04)16900-6","article-title":"Pathophysiology of airflow limitation in chronic obstructive pulmonary disease","volume":"364","author":"Hogg","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"26","key":"10.1016\/j.ejphar.2022.175187_bib30","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ejphar.2022.175187_bib31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM196806202782501","article-title":"Site and nature of airway obstruction in chronic obstructive lung disease","volume":"278","author":"Hogg","year":"1968","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175187_bib32","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.ejmech.2010.03.046","article-title":"Synthesis and evaluation of benzoxazinone derivatives on activity of human neutrophil elastase and on hemorrhagic shock-induced lung injury in rats","volume":"45","author":"Hsieh","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejphar.2022.175187_bib33","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2169\/internalmedicine.49.4010","article-title":"Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis","volume":"49","author":"Iwata","year":"2010","journal-title":"Intern. Med. (Tokyo)"},{"issue":"23","key":"10.1016\/j.ejphar.2022.175187_bib34","doi-asserted-by":"crossref","first-page":"13879","DOI":"10.1074\/jbc.270.23.13879","article-title":"Isolation and characterization of guamerin, a new human leukocyte elastase inhibitor from Hirudo nipponia","volume":"270","author":"Jung","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)02182-9","article-title":"The role of neutrophil elastase in acute lung injury","volume":"451","author":"Kawabata","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0006-291X(91)91862-7","article-title":"ONO-5046, a novel inhibitor of human neutrophil elastase","volume":"177","author":"Kawabata","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"163","key":"10.1016\/j.ejphar.2022.175187_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0241-2021","article-title":"Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy","volume":"31","author":"Keir","year":"2022","journal-title":"Eur. Respir. Rev. : Off. J. Eur. Respir. Soc."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175187_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/acschembio.9b00992","article-title":"Tutuilamides A-C: vinyl-chloride-containing cyclodepsipeptides from marine cyanobacteria with potent elastase inhibitory properties","volume":"15","author":"Keller","year":"2020","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biochi.2007.10.009","article-title":"Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions","volume":"90","author":"Korkmaz","year":"2008","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1021\/jm00164a002","article-title":"Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastase","volume":"33","author":"Krantz","year":"1990","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1165\/rcmb.2020-0410OC","article-title":"Neutrophil elastase triggers the release of macrophage extracellular traps: relevance to cystic fibrosis","volume":"66","author":"Kummarapurugu","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jamp.2009.0802","article-title":"New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways","volume":"23","author":"Lai","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2022.175187_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175187_bib44","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/toxins11120708","article-title":"Identification and characterization of ShSPI, a kazal-type elastase inhibitor from the venom of Scolopendra hainanum","volume":"11","author":"Luan","year":"2019","journal-title":"Toxins"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2022.175187_bib45","article-title":"Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase","volume":"33","author":"Lucas","year":"2013","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib46","first-page":"224","article-title":"Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster","volume":"115","author":"Lucey","year":"1990","journal-title":"J. Lab. Clin. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153560","article-title":"An in vivo model for extracellular vesicle-induced emphysema","volume":"7","author":"Margaroli","year":"2022","journal-title":"JCI insight"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175187_bib48","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.3390\/ijms23062924","article-title":"Peptide human neutrophil elastase inhibitors from natural sources: an overview","volume":"23","author":"Marinaccio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.175187_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2018.01.011","article-title":"Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance","volume":"127","author":"Marto","year":"2018","journal-title":"Eur. J. Pharm. Biopharm. : Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728222.10.2.319","article-title":"QPatch: the past, present and future of automated patch clamp","volume":"10","author":"Mathes","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"issue":"17","key":"10.1016\/j.ejphar.2022.175187_bib51","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1106955","article-title":"Small-airway obstruction and emphysema in chronic obstructive pulmonary disease","volume":"365","author":"McDonough","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9500","key":"10.1016\/j.ejphar.2022.175187_bib52","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(05)67632-5","article-title":"Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study","volume":"366","author":"Menezes","year":"2005","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.0022-202X.2004.23202.x","article-title":"Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation","volume":"123","author":"Meyer-Hoffert","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib54","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.1038\/s41598-022-10776-x","article-title":"Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action","volume":"12","author":"Milicaj","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175187_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00540-006-0391-z","article-title":"Effects of sivelestat, a new elastase inhibitor, on IL-8 and MCP-1 production from stimulated human alveolar epithelial type II cells","volume":"20","author":"Misumi","year":"2006","journal-title":"J. Anesth."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13054-020-03023-0","article-title":"Neutrophil Elastase Inhibitors: a potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?","volume":"24","author":"Mohamed","year":"2020","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175187_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/187152012800617696","article-title":"Neutrophil elastase as a target in lung cancer","volume":"12","author":"Moroy","year":"2012","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib58","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1172\/JCI115738","article-title":"Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line","volume":"89","author":"Nakamura","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib59","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1164\/ajrccm\/148.5.1351","article-title":"Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation","volume":"148","author":"O'Donnell","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib60","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1164\/ajrccm.164.5.2012122","article-title":"Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease","volume":"164","author":"O'Donnell","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175187_bib61","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1021\/jm000410y","article-title":"Development of orally active nonpeptidic inhibitors of human neutrophil elastase","volume":"44","author":"Ohmoto","year":"2001","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00769-2020","article-title":"Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis","volume":"56","author":"Oriano","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175187_bib63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nri1841","article-title":"Neutrophil serine proteases: specific regulators of inflammation","volume":"6","author":"Pham","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"6\u20137","key":"10.1016\/j.ejphar.2022.175187_bib64","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.biocel.2007.11.008","article-title":"Neutrophil serine proteases fine-tune the inflammatory response","volume":"40","author":"Pham","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175187_bib65","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jcpt.13251","article-title":"Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury\/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19","volume":"45","author":"Sahebnasagh","year":"2020","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175187_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239562","article-title":"A semi-automated method for unbiased alveolar morphometry: validation in a bronchopulmonary dysplasia model","volume":"15","author":"Salaets","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175187_bib67","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/jm3017305","article-title":"Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells","volume":"56","author":"Salvador","year":"2013","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.suronc.2007.01.003","article-title":"Neutrophil elastase and cancer","volume":"15","author":"Sato","year":"2006","journal-title":"Surg Oncol."},{"issue":"1 Pt 1","key":"10.1016\/j.ejphar.2022.175187_bib69","first-page":"L86","article-title":"Neutrophil elastase stimulates tracheal submucosal gland secretion that is inhibited by ICI 200,355","volume":"262","author":"Schuster","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(97)01284-3","article-title":"Biochemical and pharmacological characterization of FK706, a novel elastase inhibitor","volume":"337","author":"Shinguh","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175187_bib71","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1073\/pnas.84.8.2228","article-title":"Primary structure of human neutrophil elastase","volume":"84","author":"Sinha","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib72","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4155\/fmc.12.17","article-title":"Neutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors","volume":"4","author":"Sj\u00f6","year":"2012","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175187_bib73","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in primary care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.111.182139","article-title":"AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase","volume":"339","author":"Stevens","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4 Pt 1","key":"10.1016\/j.ejphar.2022.175187_bib75","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1164\/ajrccm.153.4.8616573","article-title":"Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor","volume":"153","author":"Suzuki","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175187_bib76","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<495::AID-JCP4>3.0.CO;2-K","article-title":"Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor","volume":"166","author":"Thompson","year":"1996","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1172\/JCI114699","article-title":"Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch","volume":"86","author":"Tosi","year":"1990","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175187_bib78","first-page":"556","article-title":"Anti-inflammatory activity of neutrophil elastase inhibitors","volume":"4","author":"Tremblay","year":"2003","journal-title":"Curr. Opin. Invest. Drugs: 2000"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175187_bib79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2818.2010.03481.x","article-title":"A simple tool for stereological assessment of digital images: the STEPanizer","volume":"243","author":"Tschanz","year":"2011","journal-title":"J. Microsc."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175187_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004380","article-title":"Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development","volume":"4","author":"Wang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175187_bib81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.1991.tb17022.x","article-title":"Biochemistry and pharmacology of ICI 200,880, a synthetic peptide inhibitor of human neutrophil elastase","volume":"624","author":"Williams","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175187_bib82","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/01.CCM.0000133332.48386.85","article-title":"Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study","volume":"32","author":"Zeiher","year":"2004","journal-title":"Crit. Care Med."},{"issue":"38","key":"10.1016\/j.ejphar.2022.175187_bib83","doi-asserted-by":"crossref","first-page":"18808","DOI":"10.1073\/pnas.1909972116","article-title":"SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase","volume":"116","author":"Zheng","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"12","key":"10.1016\/j.ejphar.2022.175187_bib84","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/1568026043387971","article-title":"Recent developments in the design of mechanism-based and alternate substrate inhibitors of serine proteases","volume":"4","author":"Zhong","year":"2004","journal-title":"Curr. Top. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:19:09Z","timestamp":1762143549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922004484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":84,"alternative-id":["S0014299922004484"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175187","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel benzoxazinone derivative as potent human neutrophil elastase inhibitor: Potential implications in lung injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175187"}}